Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Inhaled Molgramostim Therapy in Autoimmune Pulmonary Alveolar Proteinosis
by
Papiris, Spyros A
, Bonella, Francesco
, Yamaguchi, Etsuro
, Waterer, Grant
, Bendstrup, Elisabeth
, Inoue, Yoshikazu
, Jouneau, Stéphane
, Trapnell, Bruce C
, Kreuter, Michael
, Baba, Tomohisa
, Jouhikainen, Taneli
, Cetinkaya, Erdogan
, Kramer, Mordechai R
, Tarnow, Inge
, Campo, Ilaria
, Morgan, Cliff
, Veltkamp, Marcel
, Ilkovich, Mikhail M
, Ganslandt, Cecilia
in
Administration, Inhalation
/ Adult
/ Alveoli
/ Autoimmune Diseases - drug therapy
/ Autoimmune Diseases - physiopathology
/ Autoimmune Diseases - therapy
/ Biomarkers
/ Blood pressure
/ Bronchoalveolar Lavage
/ Colony-stimulating factor
/ Disease
/ Double-Blind Method
/ Drug Administration Schedule
/ Exercise Tolerance
/ FDA approval
/ Female
/ Granulocyte-macrophage colony-stimulating factor
/ Granulocyte-Macrophage Colony-Stimulating Factor - administration & dosage
/ Granulocyte-Macrophage Colony-Stimulating Factor - adverse effects
/ Health Status
/ Humans
/ Hypoxemia
/ Inhalation
/ Lavage
/ Life Sciences
/ Male
/ Middle Aged
/ Oxygen - blood
/ Pathogenesis
/ Pulmonary Alveolar Proteinosis - drug therapy
/ Pulmonary Alveolar Proteinosis - physiopathology
/ Pulmonary Alveolar Proteinosis - therapy
/ Pulmonary Gas Exchange
/ Rare diseases
/ Recombinant Proteins - administration & dosage
/ Recombinant Proteins - adverse effects
/ Sediments
/ Statistical analysis
/ Surfactants
/ Walk Test
2020
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Inhaled Molgramostim Therapy in Autoimmune Pulmonary Alveolar Proteinosis
by
Papiris, Spyros A
, Bonella, Francesco
, Yamaguchi, Etsuro
, Waterer, Grant
, Bendstrup, Elisabeth
, Inoue, Yoshikazu
, Jouneau, Stéphane
, Trapnell, Bruce C
, Kreuter, Michael
, Baba, Tomohisa
, Jouhikainen, Taneli
, Cetinkaya, Erdogan
, Kramer, Mordechai R
, Tarnow, Inge
, Campo, Ilaria
, Morgan, Cliff
, Veltkamp, Marcel
, Ilkovich, Mikhail M
, Ganslandt, Cecilia
in
Administration, Inhalation
/ Adult
/ Alveoli
/ Autoimmune Diseases - drug therapy
/ Autoimmune Diseases - physiopathology
/ Autoimmune Diseases - therapy
/ Biomarkers
/ Blood pressure
/ Bronchoalveolar Lavage
/ Colony-stimulating factor
/ Disease
/ Double-Blind Method
/ Drug Administration Schedule
/ Exercise Tolerance
/ FDA approval
/ Female
/ Granulocyte-macrophage colony-stimulating factor
/ Granulocyte-Macrophage Colony-Stimulating Factor - administration & dosage
/ Granulocyte-Macrophage Colony-Stimulating Factor - adverse effects
/ Health Status
/ Humans
/ Hypoxemia
/ Inhalation
/ Lavage
/ Life Sciences
/ Male
/ Middle Aged
/ Oxygen - blood
/ Pathogenesis
/ Pulmonary Alveolar Proteinosis - drug therapy
/ Pulmonary Alveolar Proteinosis - physiopathology
/ Pulmonary Alveolar Proteinosis - therapy
/ Pulmonary Gas Exchange
/ Rare diseases
/ Recombinant Proteins - administration & dosage
/ Recombinant Proteins - adverse effects
/ Sediments
/ Statistical analysis
/ Surfactants
/ Walk Test
2020
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Inhaled Molgramostim Therapy in Autoimmune Pulmonary Alveolar Proteinosis
by
Papiris, Spyros A
, Bonella, Francesco
, Yamaguchi, Etsuro
, Waterer, Grant
, Bendstrup, Elisabeth
, Inoue, Yoshikazu
, Jouneau, Stéphane
, Trapnell, Bruce C
, Kreuter, Michael
, Baba, Tomohisa
, Jouhikainen, Taneli
, Cetinkaya, Erdogan
, Kramer, Mordechai R
, Tarnow, Inge
, Campo, Ilaria
, Morgan, Cliff
, Veltkamp, Marcel
, Ilkovich, Mikhail M
, Ganslandt, Cecilia
in
Administration, Inhalation
/ Adult
/ Alveoli
/ Autoimmune Diseases - drug therapy
/ Autoimmune Diseases - physiopathology
/ Autoimmune Diseases - therapy
/ Biomarkers
/ Blood pressure
/ Bronchoalveolar Lavage
/ Colony-stimulating factor
/ Disease
/ Double-Blind Method
/ Drug Administration Schedule
/ Exercise Tolerance
/ FDA approval
/ Female
/ Granulocyte-macrophage colony-stimulating factor
/ Granulocyte-Macrophage Colony-Stimulating Factor - administration & dosage
/ Granulocyte-Macrophage Colony-Stimulating Factor - adverse effects
/ Health Status
/ Humans
/ Hypoxemia
/ Inhalation
/ Lavage
/ Life Sciences
/ Male
/ Middle Aged
/ Oxygen - blood
/ Pathogenesis
/ Pulmonary Alveolar Proteinosis - drug therapy
/ Pulmonary Alveolar Proteinosis - physiopathology
/ Pulmonary Alveolar Proteinosis - therapy
/ Pulmonary Gas Exchange
/ Rare diseases
/ Recombinant Proteins - administration & dosage
/ Recombinant Proteins - adverse effects
/ Sediments
/ Statistical analysis
/ Surfactants
/ Walk Test
2020
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Inhaled Molgramostim Therapy in Autoimmune Pulmonary Alveolar Proteinosis
Journal Article
Inhaled Molgramostim Therapy in Autoimmune Pulmonary Alveolar Proteinosis
2020
Request Book From Autostore
and Choose the Collection Method
Overview
Patients with autoimmune pulmonary alveolar proteinosis received inhaled molgramostim or matching placebo for 24 weeks. Patients receiving molgramostim had greater improvement in pulmonary gas transfer and alleviation of symptoms than those receiving placebo.
Publisher
Massachusetts Medical Society
Subject
/ Adult
/ Alveoli
/ Autoimmune Diseases - drug therapy
/ Autoimmune Diseases - physiopathology
/ Autoimmune Diseases - therapy
/ Disease
/ Drug Administration Schedule
/ Female
/ Granulocyte-macrophage colony-stimulating factor
/ Granulocyte-Macrophage Colony-Stimulating Factor - administration & dosage
/ Granulocyte-Macrophage Colony-Stimulating Factor - adverse effects
/ Humans
/ Lavage
/ Male
/ Pulmonary Alveolar Proteinosis - drug therapy
/ Pulmonary Alveolar Proteinosis - physiopathology
/ Pulmonary Alveolar Proteinosis - therapy
/ Recombinant Proteins - administration & dosage
This website uses cookies to ensure you get the best experience on our website.